Results 141 to 150 of about 60,074 (286)
Adherence to ESMO clinical recommendations for prophylaxis of chemotherapy-induced nausea and vomiting [PDF]
Background: We assessed adherence to the European Society of Medical Oncology (ESMO)/Multinational Association of Supportive Care in Cancer recommendations for prophylaxis of chemotherapy-induced nausea and vomiting (CINV) at our institution.
Aebi, Stefan +4 more
core
ABSTRACT Purpose Children with B‐acute lymphoblastic leukemia (B‐ALL) treated in resource‐intensive settings have a high likelihood of cure, but therapy is long, burdensome, and associated with substantial toxicities. Understanding parents’ perceptions of the most disruptive and difficult aspects of B‐ALL treatment is critical to future improvements in
Kellee N. Parker +7 more
wiley +1 more source
Chemotherapy-induced nausea and vomiting: exploring patients’ subjective experience
Noor Salihah,1 Nik Mazlan,2 Pei Lin Lua3 1Faculty of Health Sciences, Universiti Sultan Zainal Abidin, Kampus Gong Badak, Terengganu, 2Kulliyyah of Allied Health Sciences, International Islamic University Malaysia, Pahang, 3Community Health Research
Salihah N, Mazlan N, Lua PL
doaj
Hypnosis for anaesthetists: a systematic review and meta‐analyses
Summary Introduction Therapeutic hypnosis appears to offer psychological and physiological benefits in various medical fields, but despite increasing interest, its value for anaesthesia remains inconclusive. Methods We searched for studies of any design in which hypnosis was used for any intervention requiring the presence of an anaesthetist, alone or ...
Marie José Lahoud +2 more
wiley +1 more source
Determining predictors of underlying etiology and clinical deterioration in patients with physiologic instability in the emergency department [PDF]
Thesis (M.A.)--Boston UniversityShock is a critical state defined by inadequate oxygen delivery to tissues. It is well known in the critical care community that early diagnosis and treatment of shock are crucial to improving patient outcomes. However, in
Day, Danielle E.
core +1 more source
Abstract Although poly(adenosine diphosphate‐ribose) polymerase inhibitors (PARPis) and bevacizumab were approved as first‐line maintenance for advanced ovarian cancer (OC), evidence comparing this combination with PARPi monotherapy, especially in BRCA‐mutated/homologous recombination‐deficient (HRD) patients, is lacking.
Lingying Wu +56 more
wiley +1 more source
Abstract Background Chronic myeloid leukemia (CML) is rare in children and often shows more aggressive features than in adults. Real‐world data on the efficacy and safety of frontline nilotinib in pediatric CML in chronic phase (CML‐CP) remain limited.
Zhong Fan +30 more
wiley +1 more source

